General Information
Revision date
2018-04-05
Product name
HEPLISAV‐B [Hepatitis B Vaccine (Recombinant), Adjuvanted]
1.2.1 Relevant identified uses
HEPLISAV‐B™ is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older
Manufacturer Name
Dynavax Technologies Corporation
Icons in SDS
Company Information
company name
Dynavax Technologies Corporation
GHS Information
Signal word
Caution
Section 2
2.1 Classification of the substance or mixture
Specific Target Organ Toxicity (Repeated or Prolonged Exposure), Category 1
Signal word
Caution
Hazard statements
May cause damage to the kidneys, liver, spleen and hematopoietic system with prolonged or repeated exposure through parenteral route.
Precautionary statements
None
2.3 Other hazards
None
